Business description: GC Genome Corporation

GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.

Executive Committee: GC Genome Corporation

Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Corporate Officer/Principal 52 -

Composition of the Board of Directors: GC Genome Corporation

Director TitleAgeSince
Director/Board Member 57 30/03/2023

Shareholders: GC Genome Corporation

NameStocks%Valuation
19.6 %
4,636,500 19.6 % 19 M ₩
9.542 %
2,256,656 9.542 % 9 M ₩
Ginnovation 1st Pvt Equity Investment Partnership
4.038 %
955,039 4.038 % 4 M ₩
3.579 %
846,428 3.579 % 3 M ₩
3.316 %
784,357 3.316 % 3 M ₩

Company details: GC Genome Corporation

GC Genome Corp.

107 Ihyeon-ro 30beon-gil

16924, Yongin-si

+

http://www.gcgenome.com
address GC Genome Corporation(A340450)

Medical & Diagnostic Laboratories

Change 5-day change 1-year change 3-year change Capi.($)
+0.21%-8.82%-52.02% - 74.93M
-4.07%+2.49%+30.53%+319.35% 33.14B
-0.42%-4.19%-2.73%+8.09% 20.98B
-1.20%-1.93%-24.93%-44.26% 6.95B
+2.04%-4.37%-0.57%+66.53% 4.23B
+2.20%+4.39%+14.81%+49.81% 2.9B
-4.69%-8.34%-29.49%+822.92% 1.75B
+0.12%-2.61%-8.65%-66.59% 1.68B
+7.62%-0.81%+44.44%-24.96% 1.65B
-2.10%-0.67%+12.22%-5.22% 1.58B
Average +0.02%-1.25%-1.64%+125.07% 7.49B
Weighted average by Cap. -1.65%+1.00%+11.27%+162.35%
  1. Stock Market
  2. Stocks
  3. A340450 Stock
  4. Company GC Genome Corporation
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!